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The Role of Phospholipid and Factor VIII" in the Activation of BovineFactor X*
(Received for publication, August 5, 1980, and in revised form, November lg. 19g0)
Gerbrand van Dieijen, Guido Tans, Jan Rosing, and H. coenraad Hemker
Frotn the Department of Biochemistry, Biomedical centre, state (Jniuersity of Limburg, Maastricht, The Netherlands
- The kinelic parameters of bovine factor X activation
by bovine factor IX" have been determined in the ab_
sence and presence of Ca2*, thrombin_activated bovine
faetor- VIrI (VmJ, and- pho-spholipid (dioleoylphospha_
tidyl*oline /-dioleoylpho sptratiayis enne, I i /^Zb ; mol/mol). Factor IX" in the absence oicar*, factor VfiI", and
p_hospholipid is able to catalyzefactor I activation. The
K^ for factor X is 2g9 pu which is well above its con_
eentration in bovine plasma, about 0.2 pu. The y-* of
factor X" formation is 0.0022 mol of X".min-r.mll oi
IX"-l under these conditions. Addition o?C.il h; lilti;
effect on the kinetic constants offactor X activation by
factor Ill. I" the presence of 10 mrvr CaClg the K_ fo"r
fa9t91 X i" l8_]_pry,_and the Y** is 0.0105 mot of'X".min-'.6s1 of lX"-r. The presence of t0 pru phospholipid
dramatically decreases the K^ for factor * to O^.OOS rrr.and the tr/** becomes 0.002b mol of X".min-r.mof o-i
IX"-r. The V-* of factorX. formatiorr.lightty increases
when more phospholipidis present in ou"r eiperiments,
and there is a considerable increase ofthe K)to, factor
X at-higher phosplolipid concentrations. Therefore,
the K^ measured in the presence of phospholipid has to
b.e regarded as_ an apparent K^. The possibl" 
"*pf"""_tions f<rr this phenomenon are discusied.
- For !!r_e c-omplete lact91 X-activating complex (i.e.flctg1 IX", factor'VIIf- Ca2*, and 10 pil'pfr".ifr"fifiaj
the K^ for factor X is 0.006J p,M, and ifr"'y-*1" 
".i""i200,000-fold to 500 mol of X".min-r.m"t 
"?fX.-r. 
io
order to exert its stimulating effect on factor X activa_
tion factor VIII has to be activated with thrombin. Our
results show that factor fX" is an enzJrme which can
activate factor X at a very low rate. fhe stimulatinl
effect of pho^spholipid in factor X activation is maid!
due to an effect on the_ K^ for factor X, bringinj i"t
within the range of the plasma concentration. The stlm_
Tlg!""V effect offactor VIII" is explained by its 200,000_
fold increase of the y-* of facto. X* fo"-itiorr.
is _activated by a complex of factor VII, tissue factor, and
calcium ions (for a review, see Ref. 3), whereas the activation
of factor X via the intrinsic pathway involves the interaction
of factor IX., factor VIII, calcium ions, and phospholipid.
- 
It is now generally accepted that factor IX", factor VIII,
phospholipid, and calcium ions form a complex (1, 4_11), in
which factor IX. likely is the enzyme .""porr.ibl" for factor X
activation, since it is highly homologous to other serine pro-
teases involved in blood coagulation (12, 1g), and factor VIII,
phospholipid, and calcium ions function as cofactors (14).
Thus it is tempting to speculate that the roles of the compo_
nents of the intrinsic factor X activator are analogous to those
of factors Xu, V., phospholipid, and calcium ions in the pro-
thrombin-activating complex (7, g, g, 11, l4).
- Since the activity of factor VIII is considerably enhanced
by preincubation with small amounts of thromtrirr, it i" lit"ty
that factor VIII participates in the factor X-activating complei
in an activated form (15). Davie et al. (16,1g) reported ihat
factor VIII can also be activated with factor X". O1 interest is
the finding of Vehar and Davie (12, 1g) that thrombin-acti-
vated factor VIII is inhibited by diisopropylphosphorofluori_
date and antithrombin III, which mayhave consequences for
the way in which factor VIII functions in factor X activation.
In addition to factor IX, and factor VIII, the factor X_
activating complex requires negatively charged phospholipid
and calcium ions. It has been shown that the proteins have to
be adsorbed to the phospholipid bilayer .rrrf""" during the
activation reaction (6-11, 14). Both vitamin K_deperident
clotting factors IX" and X bind to the phospholipid surface
via calcium bridges between the y-carboxygtutamic acid-con-
taining domains of the proteins and the polar head groups of
the phospholipid (for a recent review onlhe role ofphospho_
lipid in blood coagulation, see Ref. 1g).
The purpose of the experiments described in this paper is
to examine the role of the various components of the intrinsic
factor X-activating complex by an analysis of the kinetics of
factor X activation. In the past, a direct study ofthis reaction
has been difficult for a number of reasons. Methods for puri_
fication of the proteins involved were not available, and factor
X activation could only be followed by a coagulation assay.
Such an assay is, however, only possible in tle presence of
other coagulation factors and may be influenced by a number
of feedback reactions.
A more detailed study of the activation reaction is now
possible because methods are available to purify the proteins
involved, and factor X. formation can be measured directly
either with the chromogenic substrate S 22222 (20) or througir
2 The abbreviations used. are: 5,2222, N -benzoyl-r,-isoleucyl_r,_glu_
tamyl-glycyl-r,-arginine-p-nitroanilide hydrochloride; S ZZjg, f-o_
phenylalanyl-L-pipecolyl-r,-arginine_p_nitroanilide dihydrochloride;
p.-NPG* p-nitrophenyl-p'-guanidinbbenzoate hydrochioride; RW_
X, purified factor X activator from Russell,s 
"viper 
venom; STI,
soybean trypsin inhibitor.
Blood coagulation factor Xt is a plasma glycoprotein that,
during the clotting process, is converted l"io tfru serine pro_
tease factor X, through proteolytic cleavage ofa single pepiide
bond (1, 2). Factor X, is the enzJrne that, auring it"-"o.go_
lation process, activates prothrombin to thrombin in a reaction
accelerated by factor V., calcium ions, and phospholipid.
Under physiological conditions, the activltion of factor X
can be aciomplished in both the extrinsic and intrinsic path-
ways of blood coagulation. In the extrinsic pathway facior X
_ 
* The costs of publication of this article were defrayed in part by
the payment of page charges. This article must therefore beiereby
marked "aduertisemenf" in accordance with lg U.S.C. Section lTBi
solely to indicate this fact.'The nomenclature of the blood coagulation factors used is that
recommended by the Task Force on Nomenclature of Blood Clotting
Zymogens and Zymogen Intermediates.
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the release of an acid-soruble radiolabeled activation peptide "na,?9-T" 
benzamidine at pH 2.9' Factor IX' was eluted with a linear
(21). Fujikaw a et al..(l) have shown that the activation of fi';|?T""ir*fr[:""ffn15..^cr 
Q x 250 ml) in 50 mm Tris-HCl'
iactor X is the result of the cleavage of the :ut"" 11q"{l 
-"ri""r -Bl;;;r 
i was prepared from factor X2 by incubation of
isoleucine peptide bond in the heavy chain of fact^or X both h;to, i; (S mgZrnl) with factor X, (36 pglrnl) in the presence 
of 10o
*itn f".to, fX. and factor VIII or tissue factor and factor VII. p" 
- 
pft..iit"tlpid vesicles (for preparation see below) in a buffer
as activator. Suomela and Blombdck (20) and Hultin and "ontuititie 
tZqgY I:CI 10.** 
CaCIz' and 50 mu Tris-HCl at pH
Nemerson (22)haveshown that factor X is activated at a very 
7.9 at37"b (cf, Ref.33). GeI ele-ctrophoresis in the presence of sodium
row rate by ractor rX. in the presence "r 
ph"#;ud;"";; *.S,*;:::n::i::tJ*1?*il,1T$:t"*ff*:l#"tttl::#;
calcium ions. Addition of thrombin-activated factor V^I^II-in: ["."il after 90 min of incubation EDTA was added to a final
creased the rate of factor X. formation more than 500-told 
"o""""t.utio" 
of lb mu, and the reaction mixture was applied to an
(22). _ AcA aa column 
(2.5 x 90 cm) in 0-1 u sodium citrate at pH 6.0.0
Brown et at. (ZB) reported a K^ for factor X of about 0.2 
-Factor 
X -as eluied with 0.1 u sodium citrate, pH 6'0' After pooling,
,r;;f*t;; i is aciirrated by 
human factor IX. and bovine the B-frytor X preparation was dialvzed against 
175 m'r NacI' 50 mru
factor vIII in the presence of calcium ions and.o;iln;ft. 
TriJ-HCl buffer at pH 7.9 and chromatographed on a srl-Sepharose
No activation r ractor x bv ractor IX. i1 thT';i:*{J;i ;Xt5illt;il#":11;"#'J:.t|',:?:ti"f'11ffi":Jffifl""ii""::
accessory components has yet been reported in the 'literature' 
"""" 
oftoai"- dodecyl sulfate'
In this article, we present experiments designed to study Thrombin was purified as a prothrombin activation 
product as
the kinetics of iltrinsic factor X activation' The approach is described earlier 
(24)'
similar to that followed in a study on the kinetics of prothrom . 
a4. 
F 
preparation of factor vIII, 9 liters of blood were collected
bin activation reported earlier (24). Using purified clotti:rg i1l.l::.':l" "ontuinet" 
containing 1 liter of 0'1 u oxalate' 100 mn
factors and an assay fbr factor X. with "trro*ogu.rl" 
,rru"trut"l |:liiTe"' 
20'000 units of heparin' and 100'000 Kallikrein Inhibitor
we are abre to show facror Xactivation b, f^;ii:;il:ffift .tT:t"fJ;?'J* IJ1"rffiI?tfixils$iffi:ls#'*1",1#-'l"Jjsbl
and derive kinetic parameters (K- for factor X and V-"* for iioOmg7rnl) wasaddedtotheplasma,andthesuspensionwasstined
f.;;.; i, formation) for this reaction' We determined the i"t zo "ii" 
at 4"C' The BaSor was removed by centrifugation at Ooc
effects of phosphotipid and factor VIII on these kinetic param- 
f^o:.30 ii; 
at 2000 x g' BaSor-treated plasma was stored at 
-70'c in
eters. The results of this study allow a rtrt utt"ript to ;;tht" 
3-literplastic contain-ers before further use' After thawing and ethanol
the role of phospholipid and iactor VIII" in tt " 
*'u"frurri"* of lT:1p."tt'tit" 
as described bv Schmer et al' (Ml' the suspension was
ractor Xactivation a d an appreciation "r,h" "fi'-r:l;lf# :; i:*ng::;n 3X#Hi"1H;ff,;;*,"rfri#f;"Yf;lTtJ:the intrinsic pathway to thrombin formation in uiuo' '*fifJ"1rt:Jl,T l6'','il;" "",*J;1"#.T,?l *lt,t"lXTfii*i;
EXPERIMENTAL PRocEDUREs *i#Hti,ii"Jlfli::"t"J'*H?*;lffJfLlTfr" same barbi-
Materials turic acid buffer containing}.\2Vo NaNa at pH 7'0' After about 950 mI
s 2222 ands 2238 were purchased from AB Kabi Diagnostica, :l^:it* 
factor VIII activitv appeared well separated from a large
Stockholm, Sweden. p-NpG-B was from N"rriti";i;;;11;;;;;. 
p1:1:T peak containing fibrinogen' The front of the peak (60 ml) was
Russell's viper venom, heparin sodium salt (srade l,'i#'itt-; fiff1 i:*1*.1"u 
the pooledlluate was centrituged at 190'000 x g for 21 h
mg), STI, and ovalbumini*r" out"in"a r.t- sigt' nned-s"pr't- llirYlt 
Superspeed 65 ultracentrituge at 4"C' The pellet (factor
dex A-50, sephadex G-100 and G-25, sepharo"" +s""J 68,';; Y^t]l^:-^ 
dissolved in 50 mu Tris-HCl' 175 m:u Nacl at pH 7'9 to a
CNBr-activated Sepharose 48 were from Pharmaci^. e"e-a'i *t" 
tott""ttt"tiot of 40 units/ml' Following this procedure the total
purchased from LKB. 'l'rasvlol was from stv",, L"i"tk"'"n,-c""' ::::1::t "t 
factor VIrI is- about 27a' Tbe specific activity of this
many. xaorin right w-as. rroi-son. srr *", *,,pr"i'io}L*-*tl +TlTitT,;; T"ff[i".t#:iffi,;l:ljt"Sf;J#"fJ:J*f iilX
f,Ti::o"|X'r",::]| !:t"rli:JBT::::ffi ,"""?i'""fi:fiJ3'1, til. ;;"tr;;;tit& oi p".in"a t"ooi 
vIII -u""*ed with acrotting assav
trecasas (2b) as described by Fujikaw a et al. (26). Aii;;;;;";; ;; 
isarninimum valui' since it is dependent on the dilution of the factor
were of the highest g."a" .ot-"r.ially available. 
r'r reagen* useu 
;:[tt":lnyn' 
Higher values were obtained when higher dilutions
Methods _-Il:Pt 
VIII activities were measured in a one-stage coagulation
u*uy ri-. factor Vlll-deficient plasma prepared^according,to Chan-
proteins-Bovine factor IX was purified as described by Fujikawa t*;gk"i "t;L 
(36). Fifty-pl buffer containing 0'029 ru sodium bar-
et al. (26).Bovine factors Xr and Xz wer€ pr"pu."d uJco.ding to biturate,0.029rvrsodium"""t^tu,.0.tt6uNaCi 
(pIJ7'4'0'25mc/m1
Fujikawa et al. (27)..rne-ru"L, IX, x,, and-x, p.up"."tlor,. i"." or.ino"iirri.r"-,-utrd 
0.5 mglml of kaolin (Iight) were incubated for 6
homogeneous as determined by gel electrophoresis,in ihe presence of *in-ut ii"c -ith 
50 g,I of the{actor VIII reagent' Fifty pl of a factor
sodium dodecyl sulfate. The specific activities "r 
trr""" prip*rti."., vrt*ni"i"itg "u-pt" 
*""- udded followed by the addition of 50 pI of
as determined with a clotting assay, were 100 units/mg for factor X o.o_g-3 N{d.cir, Ld the 
clotting time was measured' Activities of factor
and 145 units/mg for {actor IX, assuming 1 unit of factoi X and 1 unit VIrI wer"e-e-xpr".*"Ji" ""ltrzir 
assuming 1 unit/ml present in normal
of factor IX to be present per mI of normal bovine plasma' bovine plasma
partially purified contact product was prepar-ed.u""o.Jlrrg to No.*ul ell piot"i" p."parations-were stored 
at -70'C after dialysis against
(28) and further purified by heparin-agarose affinity chromiatographv so mu ttis-Hbl 175 
mlr NaQl at pH ?'9' Before storage at -70"C'
as suggested by @sterud and Rapaport (zgi. contaci proau"ct was tfre tactor Xr, xr, PX, 
and IX preoarations were passed through a
applied to the heparin-agarose column (l.b- -x^1b cm) in a buffer "oto*.oi 
Su-s"pharo"e (0.9 x20 cm) to reduce the small amounts
containing 0.0b u sodium?""tut" and 0.8 ru Nacl ut pii s.s and-*us of factor X, that rnight 
be present in these preparations' No thrombin
eluted with a linear gr"ii;;;;ibtio 1.0 u NaCl i;0.0b u sodium o. fuctor i" codd 5e detected 
in our proieinpreparations as deter'
acetate at pH 5.b. 
uv'u vr
Rw-x was purified from the crude venom as described by schiff- P*t"ii Concentratiins-Factor 
Xu concentrations were deter'
man et aI.(J0). Bovine factor X. was prepared from bovine iactor Xz -ln"a lv-u"tl"" site titration 
with p-NPGB according to smith (3?)'
using RVV-X according to the methoi oi Fo;iku*u et aI. (sL). Factor Ik, concentrations 
were also determined by active site titra-
Bovine factor lX" was prepared by incubating {hctor IX (2 mglml) tion wltfr p-NpGB 
(38). Factor Xr, Xz, and FX concentrations were
at 37.C with the purified contact product (g8 pglml) in a buffer a"t".mire?"f1"."o*pi"t"activationwithRvv-xfollowedbvactive
containing 50 mrrr Tris-H6l,lo ."" li"cr at p]lgrb i; the presence of site titration with p-1r1p63. 
when protein concentrations are ex'
10 mrvr CaClz (82). Atter 60 min of incubation EDTA and benzamidine pr"""-*4 io ^iffigr.-s p"r lrtl, they 
were calculated from the Am using
were added to result in final concentrations .f 15;;;;;;0 ;;, ;;^m 'f ia'g"ana rn'g for factors 
IX and IX" (32) and of 12'4 fot
.*p";lit"lt The reaction mixture was then applied to a column of factors Xr, Xz (39), and {}'
DEAE-Sephadex A-bO (1.5 x g0 cm) in 50 mrr Tris-HCl, b0 mrrr NaCI, 
pnttpil"lipia""and 
'Phaspholipid' 
Vesick Preparations-Phw-
x
E
x
6
E
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pholipid vesicle preparations were made from a mixture of 1,2-di-
oleoyl_-sz-glycero-3-phosphoserine and 1,2-dioleoyl-sn-glycero_S_
phosphocholine (25/75; mol/mol) in a buffer containing E0 mru Tris_
HCI and 175 mrrl NaCl (pH 7.9) as described earlier {24).
Measurement of the Rates of Factor X" Formation-Activation of
factor X by factor IX, at 37.C either in the presence or absence of
phospholipid, CaCl2, and,/or factor VIII, (for further experimental
conditions see legends to the frgures) was followed by transferring
small aliquots of the reaction mixture after different time intervals to
a cuvette (thermostated at 37"C| containing a buffer of 50 mrvr Tris_
HCl, 175 mu NaCl, 0.5 mglml of ovalbumin, and 10 mu EDTA at pH
7.9 in such amounts that the fina] volume became 2 r..rir; I92 ru of ihe
factor X"-specific chromogenic substrate S 2222 was also present.
Further reaction offactor IX. with factor X is prevented bv dilution
and the presence of EDTA. Since factor IX" has no amidase activitv
toward S 2222, t}re absorbance change recorded at 40b-500 ,r- o., .,
Aminco DW2 spectrophotometer (set in the dual wavelength mode)
is a measure of the amount of factor X. present in the aliquot.
From a calibration curve made with known amounts of active site-
titrated factor X,, determined under the same assay conditions as
described above, the amount of factor X" present in the aliquot can
be calculated. The rate of factor X, formation in the reaction mhture
is calculated from the amounts of factor X, present in the samples
taken at different time intervals.
The amount of factor IX, present in the incubation mixture was
chosen such that less than 27o of the factor X added is converted
dt'nng the experiment. Rates of factor X, formation are expressed as
mole factor X, formed per min per mol of factor IX. present as
determined by active site titration with p-NPGB.
For the construction of Lineweaver-Burk plots the rates of factor
X, formation were averaged from three independent determinations
at each factor X concentration. K^ and V-,, were determined bv
statistical analysis of the data as described by Eisenthal and Cornish-
Bowden (40), and lines were drawn accordingly.
Gel Electrophoresis-Gel electrophoresis in the presence of sodium
dodecyl sulfate was carried out as described in a previous paper (24).
RESULTS
The Kinetics of Factor X Actiuation in the Absence of
Phospholipid and Fdctor V/I/-Although there are no re-
ports in the literature which demonstrate that factor IX, alone
is able to activate factor X, our kinetic experiments on pro-
thrombin activation in solution (24), which showed a high K_
for the substrate prothrombin and a low Y-,*, made clear that
it might be possible to activate factor X in solution at high
factor X and factor IX" concentrations. Fig. 1 shows that
factor IX" is indeed able to activate factor X in the absence of
calcium ions, factor VIII, and phospholipid. Calcium ions
stimulate the activation about 7-fold, and there is a rather
broad optimum around 10 mu Ca2*. The Ca2* titration curves
are independent of the amounts of factor IX" and factor X
present. Pretreatment of factor IX. with 10 mu diisopropyl-
phosphorofluoridate for t h followed by dialysis did not affect
the rate of activation. Since factor IXu is probably the only
serine protease involved in blood coagulation that is not
sensitive to diisopropylphosphorofluoridate (5,41), it is un-
likely that factor X activation in the above experiment is
accomplished by trac'-'s of other serine proteases contaminat-
ing our factor IX. pr€Jparations.
To allow a kinetic analysis of the reaction, it is necessarv to
demonstrate that the rate of factor X. formation is consiant
in time and increases linearly with the amount of factor IXu
present. That this is the case is shown in Fig. 2. We also
obtained constant rates of factor X. formation proportional to
the amount of factor IX, at higher factor X concentrations
and in the absence ofcalcium ions (data not shown).
The rate of factor X. formation at various factor X concen-
trations was determined in the absence of calcium ions and in
the presence of 10 mrvr CaClz. The data are presented in the
form of Lineweaver-Burk plots (Fig. B, A and B). In the
absence of calcium ions the K- for factor X is 2gg pu, and the
Y-"* of factor X. formation rs 2.2 x 10-3 mol of X".min-r.
30 40
[a"' l
___Fr9. 1. atre Ca2* dependence offactor X activation by factor
I& in solution. Factor X, (91.4 trM) was incubated at 37.,C with
$".tol_I}. (1 1 x 10-3 pmol/ml) in 200 pl of a buffer containing b0 mnr
Tris-HCl, 175 mru NaCI, 0.5 mglml of ovalbumin at pH 7.9 in the
presence of varying amounts of CaClz. Varying amounts of extra NaCl
were present to compensate for the changes in ionic strength due to
the variation of the CaClz concentration. When no CaClz was added
the presence of 5 mu EDTA did not influence the rate of factor X"
formation. The rate of factor X, formation was calculated from the
amounts of factor X" present after 7.E and lb min of incubation.
t i m e  (  m i n  )
Frc. 2. Time courae of factor X activation with different
amounts of factor DL. Factor X, (31.4 pM) was incubated at BT"C
with varying amounts of factor IX, in 200 p,l of a buffer containing b0
mu Tris-HCI, 175 mM NaCl, 10 mM CaClz, and 0.5 mglml of ovalbu-
min (pH 7.9). After the time intervals indicated, a sample was taken
and assayed for factor X" as described under ,'Experimental proce-
dures." The amounts of factor IX. present were: fH, 0.bb x 10-3
pmol,/ml; H,-1.1 x 10-3 pmol/ml;  -4, 2.2 x l0-3 pmol/ml;
H,6.6 X l0-3pmol/ml.
mol of IX.-r. In the presence of 10 mrvr CaClz the K- is 1g1
pM, and the V-., is 10.5 x 10-s mol of X.. min-1 . mol of IX*-1.
The factor X used in these experiments was factor Xz. Hence
all subsequent experiments reported in this paper are carried
out with factor Xz as substrate.
, The Kinetics of Factor X Activation in the presence of
Phospholipid and Calcium lons-The time course of factor
X activation by factor IX" in the presence ofcalcium ions and
varying factor X and phospholipid concentrations is shown in
Fig. l*.3 To obtain a linear time course of factor X activation
.'P_oltions of this paper (including Figs. l*-b*) are presented in
miniprint at the end of this paper. Minitrint is easily read with the
5 0
( m M  )
x
o
E
o
I
x
t
E
x
o
E
'=
G
x
o
E
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B
o 0.0 4
t  /  fF""to, x) t7u-' l
Frc.3.Lineweaver-Burkplotsoffactor.X.activationbyfac.
tor IX. in the presenee and alsence of CaClz' Factor 
X' formation
;;^;;G ;;;ntrations of factor X: was measured at 
pH 7 9 at
ti"C; 2fo pl of a reaction mixture containing 50 mrvr 
Tris-HCI' 175
il*-NuCf, ouulbumin (0.5 mclml), factor IX" 
(1'1 x 10-3 prnoVml) A'
il'l;;;;"""e of 5 mu nlrre, and B' in the presence 
of 10 mu
it is essential to preincubate the phospholipid 
vesicles for 10
min at 3?'C in the presence of 50 mrt CaCIz' 
As can be seen
Itr" *t" of factor X activation is linear at factor 
X concentra-
ii""r *"ff below and above the K- determined 
at the respec-
iirr" phorpholipid concentrations (see below)'- 
i"itv it al.'(33,42) and Fujikawa et al' 
(43\ have shown
tnai-factor X, is able to caialyze a number 
of feedback
."*tiorls on the substrate factor X, especially in 
the presence
"i 
tft.."n"fioid and calcium ions' Factor X' can 
cleave a small
gii-p"p;ta; from the carboxyl-terminal end of the 
heavv
itiui., oi fu.tor X. giving rise to so-called B factor 
X' Factor X"
is also able to converf both factor X and B factor 
X auto-
catalytically into, respectively, a factor X' an-d B factor 
X' by
fruirlfuti"e a specific peptide bond in the N-Hz-terminal 
re-
gi"" 
"i,ni"avy 
chain' This second feedback reaction espe-
li"iiy -^v interfere with the determination 
of the rate of
i""l"t X activation by factor IX"' It is possible' 
however' to
.ui""l 
"*p"tit"ental 
conditions such that factor X activation
il fJ"; i" is negligible compared 
to the contribution bv
iictor IX,. hn" to* amounts of factor X' formed 
in our
"rp"rl*".rt. 
(0.05-2 pmol/ml) can easily be detected on the
Aminco DW2 spectrophotometer' When these amounts 
of
fu.to, X, are incubatei with calcium ions' phospholipid' 
and
iactor X under the conditions employed in our kinetic 
exper-
i*""t", no extra factor X. formation is detectable' As an 
extra
;;i an aliquot of the reaction mixture (see legend 
to Fig'
i;i t"x* after 30 min was analyzed by polyacrylamide 
gel
electrophoresis in the presence ofsodium dodecyl sulfate' 
The
"nfv 
pi.t"l" that couli be seen on the gel was factor X 
(data
""i.t"*"1, 
and no B factor X or factor X" is detectable' 
From
It 
"*" 
.o"i.ol experiments we conclude that the factor 
X'
formation we measure in our experiments results from 
the
action of factor IX, on a factor X'--iir" 
Cur- dependence of the rate of factor X" formation at
"*io". 
ptt.tpholipid.concentrations is shown in Fig' 4' 
'fhe
titration curves are srgmoidal, and the optimal Ca2t 
concen-
tration slightly increases with increasing phospholipid 
concen-
;;;;i;. 6h" 
"ca'* 
optimum is, however' independentlv of the
t i  fracto, x] 
(/eM-')
CaCIz. The reaction was started by the addition of factor 
IX'' After
i.i 
"iia 
rs min samples were taken and assayed for factor X' as
a"".rit"J 
""a"r 
"Experimental Procedures'" From the amounts of
factor X* found, the rate of factor X" formation was calculated' 
The
iJ""ti" 
".""t."is 
calculated are summarized in Table III'
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aid of a standard magnifying glass' Full size photocopies 
are available
;;-th; i;".r'ut of"nlotogi.ul Chemistrv' 9650 Rockville 
Pike' Be-
[  
" " t . ]  
(  mM )
Frc. 4. The Ca2' dependence offactor X activation by 
factor
IX";; th;;;"""t 
"" 
of phospholipid' Phospholipid vesicles were
incubated at 37"C in 0.3 mI of a buifer containing 50 mrvr Tris-HCl
ffi?sl, 100 mv NaCl,0.5 mglml of ovalbumin' 
andvarying amounts
;'f-a"Ci;. The ionic strength" was kept constant by the addition 
of
"lrt* 
N"Cf. After 10 min, d.gs ml of factor X (2'0 pu) was added' and
;;;lti;t, iactor X activation was started by the addition of 0'25 
ml
;il;;;ii; (0.09 prvr). Both proteins were -dissolved in a 
buffer
;;#;;;;d ffr'i*ncr (pH 7.e), 100 mY Nacl' and 0'5 mclml9l
""JU"-fi. 
fit" irnal reaction mixture contained 50 mru Tris-HCl 
(pH
;;; 05 ;c/-l of ovalbumin, an amount of NaCl to bring the 
ionic
"t.l,irgtn "fb.z1, 
CaCIz as indicated in the figure' 1'27 pu factor X' 1'5
><^ rO=; u*"fZttf of factor IX" and A--4, 25 prvr phospholipid;
a-i:{,";ii ilphospholipid; a.-4, 2q pM 
phospholipid; and
G--O; +OO 1ru pttospttolipid' The rates -o-f t'actor 
X' formation were
Jalculated from^the amount of factor X. present in the reactron
;;t";; afLer 7.5 and 15 min. Phospholipid resicles were 
prepared as
described under "Experimental Procedures'"
amounts of factor IX" and factor X present' When the 
factor
IX" concenttation is varied at a constant amount of 
factor X'
""f.i"- 
ions, and phosphotipid, the rate offactor X activation
oU."*"a is iirectiy proportional to the factor IX' concentra-
t ion  (F ig .2* ) .'- 
in" i"p""dence of the rate of factor X' formation on 
the
tu"to, X concentration was determined at 10 mM CaClz 
and
"utio"t 
phospholipid concentrations' A set of Lineweaver-
g;tk ;f"t" was obtained, two of which are shown 
in Fig' 5' An
irrt"."iti"g f"ature of the Lineweaver-Burk plots shown in 
Fig'
S i. tn" hJckey stick shape ofthe plot' Above a certain factor
thesda, MD 20014. Requesi-Do""-utt SdM-reZe, cite 
author(s)' and
includeacheckormoneyorderfor$2.00persetof 'photocopies.Ful l
rtr";;;6;s ar" uls-o included in the microfilm 
edition of the
Journal that is available from Waverly Press'
X concentration, no further increase of the rate of factor X"
formation is observed. The factor X concentration at which
the Lineweaver-Burk plot levels off increases with the phos-
pholipid concentration. A number of explanations is possible
for this phenomenon. Since they depend on the model for the
mode of action of phospholipid in the factor X-activating
complex, the explanations will be treated in the discussion.
For calculation of the kinetic parameters K- and V*.*, we
only used experimental points where the rate of factor X
activation is still dependent on the amount offactor X present.
At 20 ptvt phospholipid the K^ for factor X is 0.14 pu, and
the V-," of factor X, formation is 5.8 x 10-3 mol of X.. min-l .
mol of IX,-1. The rates are expressed per mol of factor IX.
added. Compared with the results obtained in solution, it is
seen that phospholipid lowers the K^ for factor X about 2000-
fold with only little effect on the l/-"* of factor X. formation.
The kinetic constants determined at different phospholipid
concentrations are summarized in Table I. There is a gradual
increase of the K- for factor X when the phospholipid con-
centration is raised. The V-," of factor X. formation also
increases with the phospholipid concentration. The variation
of V-", may be due to the fact that the V-u, is calculated from
the amount of factor IX^ added, while it is actually the amount
of factor IX, bound to the phospholipid surface at each
phospholipid concentration that determines the rate of factor
X activation. The kinetic parameters of factor X activation in
solution are such that free factor IX. does not contribute to
factor Xu formation. Therefore, a variation of the amount of
factor IX, bound due to the variation of the phospholipid
concentration will then be reflected in the observed value of
V-"*. In that case extrapolation ofa double reciprocal plot (1/
Vmar u€tsus 1/[phospholipid]) at a constant factor IX* to
infinite phospholipid concentration yields the Y-u* for bound
factor IX. (Fig. 3*). The V-., calculated from this plot is 0.08
mol of X.. min*l .mol of IX"-r (bound).
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0.058
0.139
0.363
0.409
0.525
0.822
1.83
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The Kinetics of Factor X Actiuation in the Presence of
Phospholipid and Factor VIII*-From many reports in the
literature, it is obvious that factor VIII participates in the
factor X-activating complex in an activated form (1b, 18,22').
The activity of factor VIII in the intrinsic factor X activation
is considerably enhanced by prior incubation with trace
amounts of thrombin. The effect of thrombin on the activity
of factor VIII is evaluated in general with a clotting assay.
Feedback reactions by thrombin and other serine proteases
accumulating during clotting hamper a study of the quanti-
tative aspect of this activation. Therefore, we aimed to set up
a system in which the activation of factor VIII by thrombin
can be followed directly by measuring its effect on factor X
activation.
The experimental set-up is as follows. Factor VIII is incu-
bated with varying amounts of thrombin, and the time course
of activation is followed by transferring after different time
intervals aliquots of this activation mixture to a reaction
mixture containing a small amount of factor IX, (2000 times
lower than in the experiments of the previous section), factor
X, CaClz, and phospholipid. From the amount of factor X,
formed aftet 2,3, and 4 min in this mixture, the rate of factor
X. formation is calculated. This rate is taken as a measure of
the amount of factor VIII. present in the aliquot.
The time course of factor VIII activation by various
amounts of thrombin was measrued with this assay and is
shown in Fig. 4*. Incubation of factor VIII with thrombin
results in a rapid increase offactor VIIL activity followed by
a decrease. Both the rates of activation and inactivation
increase with the thrombin concentration. When either factor
VIII or thrombin is omitted from the activation mixture no
factor X. is formed in the reaction mixture. This experiment
stresses again that factor VIII has to be activated before it
can exert its stimulating effect on the activation of factor X
by factor IXu.
We were unable to show activation of factor VIII by factor
X. either in the presence or in the absence of phospholipid
and calcium ions. This is in contrast with earlier reported
findings (16, 18) that factor X, can activate factor VIIL We
have to emphasize, however, that the amount of factor X, is
limited to 0.5 1tg/rrrJ, since higher amounts of factor X, cause
autocatalytic factor X activation in the assay system.
In our further experiments, factor VIII is activated by
incubation with 0.04 prg of thrombin/ml for 5 min at B7oC.
The time course of factor X activation in the presence of
factor VIII", calcium ions, and 5, 10, or 25 plr phospholipid
was determined at a low and a high factor X concentration
(Fig. 6). Factor VIII", activated as described above, was added
to a mixture of phospholipid (pretreated with CaClz), CaClz,
factor IX,, and factor X preincubated 3 min at BZ.C. A typical
time course of factor X activation shows a lag period of 1-2
min, a 4-min period with an apparent constant rate of factor
X, formation followed by a decrease of the activation rate. We
have been unable to shorten the lag period by changing the
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0.00579
o.0226
0.0219
0.0%r
0.0295
0.o474
0.0437
0  5  t o
1/ l rac to r  X f  ( f r t )
Frc. 5. Lineweaver-Burk plots offactor X activation by fac-
tor IX, in the presence of phospholipid. Phospholipid vesicles
were preincubated at 37oC in a buffer containing b0 mrvr Tris-HCl,
175 mM NaCl, and 50 mltl CaClz at pH 7.9. After f0 min, 0.1 ml of the
phospholipid mixture was transferred to 0.35 ml of a buffer containing
50 mu Tris-HCl (pH 7.9), 175 mrvr NaCl,0.b mglml of ovalbumin, and
varying amounts of factor X. Four min later, factor X activation was
strated by the addition of 0.05 ml of factor IX. (0.11 u.rvr). The final
reaction mixture contained: 50 mu Tris-HCl (pH 7.9), l7b mru NaCl,
0.4 mg/ml of ovalbumin, 10 mu CaCl2, 1,09 x 10-5 pmol,/ml of IX,,
varying amounts of factor X, and A-4, b0 prvr phospholipid;
H, 200 pu phospholipid. The rate of factor X, formation was
calculated from the amount of factor X, present in the reaction
mixture after 7.5 and 15 min. Phospholipid vesicles were prepared as
described under "Experimental Procedures." The kinetic parameters
calculated are summarized in Table I.
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Frc. 8. Lineweaver-Burk plots of factor X, formation bv
f1ct9r IX" in the presence of factor VIII* and varying amount-s
of phospholipid. The rate of factor X. formation at various factor X
concentrations was rneasured at H, b prvr phospholipid,
H, 10 pru phospholipid, and A-4, 2b prvr phospholipid in the
presence of activated factor VIII (8 units,zml) and CaClz (2.5 mu).
For experimental details, see legend to Fig. 7.
plots are also summarized in Table II. The K^ for factor X
appears to be dependent on the phospholipid,concentration
to the same extent as observed in the experiments carried out
in the absence of factor VIII" (ci Table I).
Kinetics of Actiuation of Factor X1 and B FactorX-Since
all experiments reported in this paper were carried out with
factor Xz, we were interested whether factor Xy and B factor
X are kinetically identical. Therefore, a number of experi-
ments were repeated using factor Xr and factor BX as sub-
strate. Both factor Xr and BX showed the same kinetics of
activation as factor Xz.
DISCUSSION
Previous studies on the intrinsic activation of factor X
suggest that the activator is a complex composed of factor
IX., factor VIII", phospholipid, and calcium ions (4-11, 22,
23). Several properties offactor IX. indicate that it is a serine
protease and hence will be the enz5,.rne that actually activates
factor X. Factor IX. is highly homologous to other serine
proteases involved in blood coagulation (18) and has an ester-
ase activity toward synthetic arginine esters (44). Its enzy-
matic activity is also inhibited by well known serine protease
inhibitors like antithrombin III (44,4b1 and hirudin (46).
When it is accepted that factor IX, is the enzyme in the
factor X-activating complex it is plausible to assume that
factor VIII, phospholipid, and calcium ions act as cofactors to
factor IX,. In this concept the roles of factor IX", factor VIIL
and phospholipid are analogous to those of, respectively,
factor X", factor V,, and phospholipid in the profhrombin-
activating complex.
If this model is correct one would expect that factor IX. can
activate factor X in the absence of accessory components.
Although no activation of factor X by factor IX, in solution
has been reported yet, Hultin and Nemerson (22) have shown
that factor IX" in the presence of phospholipid and calcium
ions, but without factor VIII, slowly activates factor X. The
rate of factor X activation was substantially increased when
thrombin-activated factor VIII was included in the reaction
mixture. A rate enhancement caused by factor VIII has been
reported in several other papers (L, ZO, 22,28). These findings
extend the analogy with the prothrombin-activating complex.
The accessory components phospholipid and factor VIII"
stimulate factor X activation by factor IX., just as phospho-
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Composition of factor X-acti-
varmg mxture
IX"
IX", CaCl2
IX., CaCL, PL" (10 prvr)
IX,, CaClz, PL (10 prvr),
VUI, (11 units/rnl)
lipid and factor Vu increase the rate of conversion of prothrom_
bin to thrombin by factor X" (47 , 48).
In this paper we report that factor IX" in solution. in the
absence of accessory components, is able to catalyze the
activation of factor X. This finding supports the concept that
factor IX. is the enzpne in the intrinsic factor X-activating
complex. It proved possible to carrSr out a kinetic study and
obtain the kinetic parameters (K^ and V-,*) for the activation
reaction in solution. We determined a K^ for factor X of 2gg
prr and d V^^* of 2.2 x 10-3 mol of X..min-l.mol of DL-l.
The presence of calcium ions has little effect on the kinetic
parameters (Table III).
The fact that we were able to study the kinetics of the
reaction in solution made it possible to determine the effect of
phospholipid and factor VIII" on the kinetic parameters of
factor X activation. Such a kinetic analysis offers the oppor-
tunity to gain insight into the role of phospholipid and factor
VIII, in the mechanism of factor X activation. Knowledge of
the kinetic parameters is also essential to evaluate the contri-
bution of intrinsic factor X activation to factor X, formation
at physiological conditions.
The kinetic parameters for different factor X-activating
mixtures are summarized in Table III. Both phospholipid and
factor VIII, cause important changes of,the kinetic parameters
of factor X activation. In the presence of 10 prvr phospholipid
the K^ drops from 181 prvr to 0.058 ;ru, while there is little
change of the V*.,. The effect of factor VIIL is mainly
restricted to the V*.,. In the presence offactor VIII. the V-"*
increases about 200.000-fold.
The data presented in this report have important implica-
tions for the mode of action of phospholipid in the mechanism
of intrinsic factor X activation. Phospholipid has little effect
on the catalytic activity of factor IX.. For free factor IX. a
V*", of 0.01 mol of X.. min-t .mol of IX.-r is measured (Table
III), and for phospholipid-bound factor IX* the V-., is 0.0g
mol of X,.min-l.mol of IX"-r. The K- for factor X is dramat-
ically decreased in the presence of phospholipid. There is,
however, a considerable increase ofthe K- at higher phospho-
lipid concentrations, so a K- measured in the presence of
phospholipid has to be regarded as an apparent K*. In a
previous paper (24\, we have shown that in the prothrombin-
ase complex phospholipid causes a marked decrease of the K_
for prothrombin, and the K^ is also raised at increasing
phospholipid concentrations. Hence it seems plausible that
the mechanistic basis for the mode of action of phospholipid
in both complexes is identical. Two models have been pio-
posed to explain the role of phospholipid in prothrombin
activation. Because of the similarity between prothrombin
and factor X activation with respect to phospholipid involve-
ment, these models are also applicable to factor X activation.
In previous papers (24,49), we suggested that the enz;rme and
substrate are bound to the phospholipid surface and that the
amount of bound subtrate determines the rate of activation.
An increased local substrate concentration at or in the vicinitv
Tesln III
Effect of the accessary *ry::frnilkinetic pararneters of factor
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K-.pp
pM ;ax$X'-^"t'  14"
259 0.w22
181 0.0105
0.058 0.0v247
0.063 500
" PL, phospholipid.
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of the phosph,lipid surface (cf, Ref' 50) can ex-plain the large increased, which in the co-factor model for factor VIII. woulddecrease of the K- observed in the presence of phospholipii. mean that factor IXu becomes saturated with co-factor. underThe K"' measured' expressed in terms of added r"u.t.ul",-i. t^ille conditions factor IX, has a proteolytic activity compa_an apparent K-' which increases when increasing amounts'oi r.nL t" ractor x*i., ttr" pritn"o-uin-activating complex (24,phospholipid are present' since at higher pnotpioripiJ .on- isi'""a to factor vII, in the extrinsic factoi Xlctivatingcentrations more substrate has to be aaaedio attain ihe local complex (21) determin"a i., th" presence of saturatingconcentration at which the enzyme bound to the surface works u,oo,r.rt. of their respective co-factors v, and tissue factor.at Yz V^"". A different model is proposed by_Nelsestuen (;rj. e""1ir" increase 
"f 
th" K;for factor X observed ullrr"r"uri.rgHe suggests that the enzyme-bound at the_ph*ph;li; i ; ia"ctorVll l.concentrationswehavenointerpretationyet.Asurface is active on the soluble substrate. err.sprroupla 
"ur..". 
-o." 
"rt"r"rrre 
kinetic analysis will be required to explain thisa decrease of the apparent K^by altering tnu uinang,arrinitv pt uno*.rrorr. The high molecurar weight form of factor vIIIof the active site of the enzyme for its substrat". Attho.rgh *as used in the expiri.r.".rt. described in this paper. ThisNelsestuen does not mention in his paper the increase of tile f."p*utio.r, generally referred to as factor vIII,/von wille-apparent K' at higher phospholipid concentration, this can trand fa.to, tr""t"t vrrrl"wF) is a complex of low molecularalso be explained in this model' Binding of the substraie 
- 
"igr,t 
factor vrII coagulant activity and high molecularreduces the concentration in solution' At"a higher phospho- rv"iEnt vonrMillebrand piatelet aggregating activity. Recently,lipid concentration more substrate is bound, and hence more veh? and Davie (1g) *o""u"d"d in obtaining a highly purifiedsubstrate has to be added to reach a substrate level in sol,rtion ra"to, vtu .ou^g,ruJ u.ii"iti. rt ,ril ue interesting to compareat which the ehzyme functions at 1/z v^^*. It will be obvious tn" 
"rr""t* 
of fictor vtti coag,ta.rt activity and factor VIII/that both models can qualitativel-v explain the effect of phos- 
"we 
on the kinetics of factor X activaton.pholipid on the K^ for factor X of thu i.tt.i.tsic i'rctor X The physiological significance of the alteration of kineticactivator reported in this paper' The flattening of the Line- patleters will be obvlious. Intrinsic factor X activation re-weaver-Burk plots observed at high factor X concentrations quires phospholipid u."unr" ii lowurs the K*for the substrateis most easily explained in the model where bound factor X is to within tl",3l-*r oi in.lru.-u concentration (0.2 pwt). Atthe substrate' At high factor X concentrations the binding tigh;no"ptrolipid-conceniriilonstner.rises,however,abovesites for factor X at the phospholipid vesicles become satu] i-ni-lu.*u factor X 
"o.r"".rtra6on. 
It is possible that thisrated' The addition of extra factor k cannot further in..uu"u ft 
"rio*".ron 
plays a role in the physiologic regrrlation ofthe bound factor X concentration, and consequently there is iactor X. formation. Factor vIII. via its effect on v-,* in-no further increase in the rate of activation. At r,kir". ptro.- ;;;;;;r the rate of factor X activation to a level where sufti_pholipid concentration more factor X is required io saturate 
"r"'i, 
ru"to. x. is formed to 
"orrtrot 
h"mostasis. It is interestingthe binding sites' and hence the leveling off occurs at a higher to compare the kinetic parameters that we found for thefactor X concentration' It is interesti"ng to notice that the intrinsic factor X activator *itn tno." of the extrinsic factorbreak point in the Lineweaver-Burk plots*is observed at factor X aclivator determined by silverberg et al- (21).They foundX concentrations about equal to the concentration of bindin g u K) b, f.r"r:_r-_T of 0.34 pu and a V^"* of1g00 mol of X,.sitesforfactorXpresent.on^thekindof phospholipidvesiclei mi.rlr.*ol of VII.-1.:ffrrr" ln" catalytic efficiency, V^^"/K^,used in our experiments (0'011 iru binding sites/plr phospho- r* uoti, activator systems is about equal. These data willlipid; Ref' 52)' A qualitative expianation oithe above phenom harre to be taken into consideration in a discussion about theenon in the model where soluble factor X is the substlate is 
"-rtriu.rtio., 
of the intrinsic and extrinsic factor X activationnot readily available. In order to determine which of the two to iu"Jo. X. formation in uiuo.models is valid, the exact binding parameters of factor X
binding to the phospholipid vesicles under the conditions of Aclznowledgments-wewould like to thank Mr. J. H. L. Franssenour kinetic experirrrents have to be known. In that 
".."- 
tfr" for the preparation of factor vIII, Mrs. G. w. Janssen-Claessen lbramounts of bound and free factor X at each individual point :I:"lt^":t 
technical assistance, Dr. Y. Nemers"" rr. malvi.oviding
of the Lineweaver-Burk plot can be calculated, ,"d i;;;;; !h9,3ogq,tu. 
program for calculation of the kinetic 
"orriJrrl, Mrr.veriried whether the reacrion beys Micha"bil;il; ffi"r j;,y"i g:'i:.Xt"#:i t:1"#*iffiilr:i":*:,-.:::#fifr,l:
ics with bound or soluble s*bstrate. At the moment experi- chromogenic substrates,r."Jirr'o* laboratory were kindly donatedments are underway in our laboratory in which binding and tfan xani Diagnostica,
kinetic pararneters for various phospholipid mixtures are de_
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3442 Bl'oodCoagulation:
Supptmntary  mate . ia t  to
TH€ RoLt 0p PH0SpH&rpIo ANo FACToR VtIIa Iil THE ACTIVAIIoX 0F BoVIlt FACToR x
Gerbrand van Oie i jen ,  Gu ido  Tans ,  Jan  Ros ing .nd  H.  C@nraad Hemker
F ig .  I t  -  T r f t  course  o f  fac to r  X  .c t i va t ion  by  fac to .  IX ,  in  the  presence o f  phosphot ip id
and cacla. phospnotidia ,"ri"r"i *."I*oli i lo n*i :r% r"'o ruri l i--t"tnins
50 il Tris-HCl, 175 nil i lac] and 50 i l cacl2 (pH 7.9). 0.15 mt of this phospholipid suspsn_
s ion  ras  added to  I .2  h l  o f  a  reac t ion  F i r tu re  conta in ing  50  i l  T r is_ f fCt ,  U5 i l  tac l ,  0 .5
ng/n l  ova lbmla  and fac to r  X  (anouf , ts  ind ica t€d  be td)  a t  p f f  7 .9  an j  37oC.  A f te r  3  n jn ,
fac to r  x  .c t i ra t ion  las  s ta r ted  by  the  add j t jon  o f  0 . lS  ml  fac to r  IX .  (0 .067 ! f f ) .  The f ina l
reac t ion  f i i x tu r !  co f , td ined:  50  i l  T r is -HCt ,  l i5  i l  i l ac t .  tO m CaCt l  O.4S E/n t  ova lbmin ,
6 .7x lO_6 uo les fn l  i i t to r  IX ,  ana a-^  ,  l0  uH phospho l ip id ,  O.0Z ! t  fac to r  X ;  r - r  ,
10  ! i l  phospho l ip id ,  0 .1  ! t  fac to r  X i  O-a  ,  100 u i l  phosphot ip jd ,0 ,2  !H fac to r  r ;  o_O ,
100 ! i l  phospho l ip id ,  1 .0  !H fac to r  X .  A f te r  the  r i ru  in tena ls  ind ica ted  in  the  f igure ,
s i lp les  were  ta len  and nssayed fo r  fac to r  Ia .  phospho l ip id  ves ic les  vere  prepared as  des_
cr ibed in  the  exp€r i f tn t i l  o roc&ures ,
The Actiuation of :Bouine Factor X
0.1
E
E
't  
/ lphosphol ipid]  ( /" ' '  )
Fig .  3 r  -  Doub le  rec ip roca l  p lo t  o f  Vnax  as  a  func t ion  o f  the  phospho i rp rd  concent ra t ron .
The fac to r  X  ac t iva t ing  d ix ! / re  cons is&d o f  fac to r  Ixa ,  CaCl2  and phosphot ip id .  Th is  p lo t
contd i rs  da ta  sumr i red  in  Tab le  I .
Fig. 4r - Tire course of activatlon ol factor VItl uith various arc@ts of thdin. Faclor
V i I I  (10  U/ml )  ras . incubated  n t  toc  r i th  ydr ious .@sts  o f  thMin  in  a  bu t re r  mnu in ing
50 i l  T r is -HCl ,  175 i l  l i c l  a t  p f f  7 .9 .  The mhts  o f  thd in  pEsent  d re  ind i€ . ted  in  tne
f igure .  A f t6 r  th  t i c  ln te rva ls  ind ica ted  in  t to  f igure ,0 .1  n l  o f  th js  incubat ion  n ix tuE
$s transf€rred to 0.9 El of a Eectlon frixtuE'cootalning all furtfur crydenrs fuiEd
for  fac to r  X  ac t iv r t ion .  Ihe  f ina t  cdcent ra t jons  in  the  Eac t ion  mix tu re  (1  h t )  re re :
50  d  Tr is -HCl  (pH 7 .9) ,  175 i l  i l ac t ,  lO  i l  CaCl? ,  0 .5  ng lmt  ova lbmin ,  0 .34  x  l0 -8
wles /ml  fac to r  IX" ,  0 .015 uX fac to r  X .nd  12 .5  ;X  phospho l ip id .  The phosphot ip id  ves ic ies
sere preincubated for l0 min at 37oC in a buffer containiog S0 il Tris_XCl, I75 il {acl and
50 i l  CdCl2  k fo re .dd l t ion  to  tk  reac t ion  n ix tu re .  2 ,  3  and 4  min  a f te r  the  add l t ion  o f
factor VIIIa aliquots frm the reactio mixture rere assay€d for factor I,, The rat€ of
f tc to r  X .  fo@t ion  ras  ca lcu la ted  f rd  Se ammts  o f  fac to r  Xa present ;n  these a t iquots .
Phospho l ip id  ves ic les  re re  p repa.ed  as  descr ibed mder  , ,ErFr i ;n ta l  p rocedures , ,
o f ro t  lX .  /h r
Fis. 2r - lE-gll9$-91-8*!Ilxa on the rate or factor x activation jn the presence of
phospho i ip id .  Phosphor ip id  ves ic res  re re  p .e incubated  a t  370c  in  50  d  Tr is -Hcr ,  I /5  d  Nacr ,
50  mi l  Cac lz  a t  p l  7 .9 .  A f te r  l0  min ,  50  ! l  o f  th is  suspens ion  was t rans fer red  to  300 ! t  o f  a
buf fe r  con ta in ing  50  i l  T r js -HCl ,  175 d  XaCt ,  0 .S  mglmt  ova tbumin  and 0 .833 !X  fac to r  X  a t
pH 7  9 .  A f te r  4  min  in€ubat ion  a t  370c ,  fac to r  r  ac t i va t ion  Ms s ta r ted  by  the  add i t ton  o f
t50  u l  50  d  Tr is -HCl  (pH 7 .9) ,  t75  i l  NaCl  bu f fe r  con ta in ing  0 .5  ng /mt  ova tbumin  and
var ious  amounts  o f  fac to r  IXa .  The f ina t  reac t ion  mix tu re  conta ined 50  d  Tr is_HCt  (pH 7 .9) ,
175 d  NaCl ,  10  i l  CaCl2 ,  50  ! f f  phospho l ip id ,0 .5  ! i l  fac to r  I ,  0 .5  ng lmt  ova tbumin  dnd
arcunts  o f  fac to r  IXa  as  ind ica ted  in  ihe  f igure .  The ra te  o f  fac to r  X  ac t iva t ion  {as  ca l_
cllated frm the anounts of factor Xa present in the reaction mixture after 5 and l0 min.
Th€ phospho l ip id  ves ic tes  were  prepared as  descr ibed in  th€  exper i f tn td t  p rocdures .
omol  lX .  /h l
F ig .  5 t  -  The e f fec t  o f  fac to r  IX  m r l
c 
h€ rate of factor X activation in the presence of
fac ton  V l l Ia  and phosphot ip id .  Fac tor  V I l l  ( lO  U/ml )  was  ac f iva ted  a t  37oC r i th  0 .04  ug ln t
th rd in  in  a  bu f f€ r  con ta in iog  50  i l  T r is -HCt  (pH 7 .9)  and l7g  i l  XaC1.  A thr  5  n in ,  0 .1  n l
of the activation dxture yas added to 0.9 mr of a r*ction mirture, The final concenirations
in  the  reac t ion  n ix tu re  re re :  50  d  r r i s -nc t  (pH 7 ,9) ,  175 i l  i l ac l ,  l0  d  CaCl , ,  0 .5  mg/mt
ova lbur in ,  0 .01  ! t  fac to r  X ,  l0  !X  phospho l ip id ,  fac to r  V I I I :  and fac to r  IX ,  a ]  inAtca tea .
Before  use ,  the  phospho l ip id  ves ic tes  p re  p re incub i td  fo r  iO n in  a t  37oC ;n  S0 i l  I r i s_HCl .
175 i l  i l ac l ,  50  d  cac lz  a t  pH 7 .9 .  A f te r  2 ,3  and 4  min  a t iwots  * r€  ta ten  f r t r  th€  reac t ion
mixtures and-mre sssayed for factor Xa, The rate of fictor Xa fomtjon tas calculated frm
the muni of factor Xa present in these aliquots. phospholipid vericles rere pEgared as
descr ibed uder  " f rper j@nta l  Procedures- .
i
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